Skip Navigation


Rheumatology Advance Access originally published online on January 10, 2008
Rheumatology 2008 47(3):375; doi:10.1093/rheumatology/kem281
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
47/3/375    most recent
kem281v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ottewell, L.
Right arrow Articles by Walker, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ottewell, L.
Right arrow Articles by Walker, D. J.
Related Collections
Right arrow Spondylarthropathies
Right arrow Soft Tissue Rheumatism
Right arrow Pharmacology
Right arrow Rheumatoid Arthritis
Right arrow Systemic Lupus Erythematosus and Autoimmunity
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

LETTERS TO THE EDITOR

Co-proxamol: where have all the patients gone?

L. Ottewell and D. J. Walker

Musculoskeletal Unit, The Freeman Hospital, Newcastle-upon-Tyne, Tyne and Wear, UK

Correspondence to: D. J. Walker. E-mail: d.walker@ncl.ac.uk; david.walker@nuth.nhs.uk

The first 10% of the full text of this article appears below.

SIR, The Committee on Safety of Medicines (CSM) advised withdrawal of co-proxamol in January 2005 as it was judged that the risk of accidental death by overdose and the drug's frequent use in suicide outweighed its benefits as a painkiller. We were struck by the number of patients who seemed to be coming to the clinic complaining that they were unable to find an effective alternative. A typical complaint would be that they had been on co-proxamol . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?